Effects of Intravenous Nefopam on Pain Relief in Patients with Acute Postoperative Pain: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Although intravenous nefopam has been used for opioid-sparing strategy and pain relief, randomized controlled trials (RCTs) have shown inconsistent findings. Methods: We searched core databases, PubMed, EMBASE, and the Cochrane library for RCTs on this research question in December 2022. Standardized mean difference (SMD) and weighted mean difference (WMD) were calculated using a random-effects meta-analysis.Results: Of 708 studies identified from the databases, a total of 17 RCTs (n=1,173 patients) that met the inclusion criteria were included in the final meta-analysis. Overall, the consumption of cumulative opioid analgesics was significantly lower in the nefopam group than the control group, on arrival in the postanesthesia care unit (PACU) (SMD, −0.70; 95% confidence interval [CI], −1.01 to −0.39; I2= 55.1%; n=7), at 24 hours (SMD, −0.65; 95% CI, −1.09 to −0.20; I2=87.4%; n=9), and 48 hours (SMD, −0.82; 95% CI, −1.40 to −0.24; I2=85.6%; n=6) after surgery. It also showed a significant lower pain score, on arrival in the PACU (WMD, −0.80; 95% CI, −1.27 to −0.32; I2=69.6%; n=7) and 24 hours (WMD, −0.48; 95% CI, −0.79 to −0.16; I2=0.0%, n=5). However, publication bias was observed (asymmetrical funnel plot and P for bias=0.005).Conclusions: Intravenous nefopam showed an opioid-sparing effect and pain relief in the management of patients with acute postoperative pain.
Abstract
Background: Although intravenous nefopam has been used for opioid-sparing strategy and pain relief, randomized controlled trials (RCTs) have shown inconsistent findings. Methods: We searched core databases, PubMed, EMBASE, and the Cochrane library for RCTs on this research question in December 2022. Standardized mean difference (SMD) and weighted mean difference (WMD) were calculated using a random-effects meta-analysis.Results: Of 708 studies identified from the databases, a total of 17 RCTs (n=1,173 patients) that met the inclusion criteria were included in the final meta-analysis. Overall, the consumption of cumulative opioid analgesics was significantly lower in the nefopam group than the control group, on arrival in the postanesthesia care unit (PACU) (SMD, −0.70; 95% confidence interval [CI], −1.01 to −0.39; I2= 55.1%; n=7), at 24 hours (SMD, −0.65; 95% CI, −1.09 to −0.20; I2=87.4%; n=9), and 48 hours (SMD, −0.82; 95% CI, −1.40 to −0.24; I2=85.6%; n=6) after surgery. It also showed a significant lower pain score, on arrival in the PACU (WMD, −0.80; 95% CI, −1.27 to −0.32; I2=69.6%; n=7) and 24 hours (WMD, −0.48; 95% CI, −0.79 to −0.16; I2=0.0%, n=5). However, publication bias was observed (asymmetrical funnel plot and P for bias=0.005).Conclusions: Intravenous nefopam showed an opioid-sparing effect and pain relief in the management of patients with acute postoperative pain.
참고문헌 (38)
- Ballantyne JC, "Opioid dependence and addiction during opioid treatment of chronic pain", Pain, 129(3), pp.235~255 (2007)
- Lee M, "A comprehensive review of opioid-induced hyperalgesia", Pain Physician, 14(2), pp.145~161 (2011)
- Kehlet H, "The value of"multimodal"or"balanced analgesia"in postoperative pain treatment", Anesth Analg, 77(5), pp.1048~1056 (1993)
- White PF, "Multimodal analgesia : its role in preventing postoperative pain", Curr Opin Investig Drugs, 9(1), pp.76~82 (2008)
- Girard P, "Nefopam analgesia and its role in multimodal analgesia : a review of preclinical and clinical studies", Clin Exp Pharmacol Physiol, 43(1), pp.3~12 (2016)
- Evans MS, "Nefopam for the prevention of postoperative pain : quantitative systematic review", Br J Anaesth, 101(5), pp.610~617 (2008)
- Tramoni G, "Morphine-sparing effect of nefopam by continuous intravenous injection after abdominal surgery by laparotomy", Eur J Anaesthesiol, 20, pp.990~992 (2003)
- Du Manoir B, "Randomized prospective study of the analgesic effect of nefopam after orthopaedic surgery", Br J Anaesth, 91(6), pp.836~841 (2003)
- "Ann Fr Anesth Reanim", 2005, 13~18
- Aveline C, "Postoperative analgesia and early rehabilitation after total knee replacement : a comparison of continuous low-dose intravenous ketamine versus nefopam", Eur J Pain, 13(6), pp.613~619 (2009)
- Park JH, "Effect of nefopam for patient-controlled analgesia after laparoscopic gastrectomy", Anesth Pain Med, 10(3), pp.175~179 (2015)
- Kim SY, "Nefopam as an adjunct to intravenous patient-controlled analgesia after renal transplantation : a randomised trial", Acta Anaesthesiol Scand, 59(8), pp.1068~1075 (2015)
- Choi SK, "Comparison of effects of intraoperative nefopam and ketamine infusion on managing postoperative pain after laparoscopic cholecystectomy administered remifentanil", Korean J Anesthesiol, 69(5), pp.480~486 (2016)
- Jin HS, "Opioid sparing effect and safety of nefopam in patient controlled analgesia after laparotomy : a randomized, double blind study", J Int Med Res, 44(4), pp.844~854 (2016)
- Li M, "Intravenous analgesics for pain management in postoperative patients : a comparative study of their efficacy and adverse effects", Trop J Pharm Res, 15(8), pp.1799~1806 (2016)
- Moon JY, "The effect of nefopam on postoperative fentanyl consumption : a randomized, double-blind Study", Korean J Pain, 29(2), pp.110~118 (2016)
- Park HJ, "Analgesic effects of nefopam in patients undergoing bimaxillary osteotomy : a double-blind, randomized, placebo-controlled study", J Craniomaxillofac Surg, 44(2), pp.210~214 (2016)
- Na HS, "Preventive analgesic efficacy of nefopam in acute and chronic pain after breast cancer surgery: a prospective, double-blind, and randomized trial", Medicine (Baltimore), 95(20), pp.e3705~ (2016)
- Cuvillon P, "Opioid-sparing effect of nefopam in combination with paracetamol after major abdominal surgery : a randomized double-blind study", Minerva Anestesiol, 83(9), pp.914~920 (2017)
- Kim EM, "The effect of nefopam infusion during laparascopic cholecystectomy on postoperative pain", Int J Med Sci, 14(6), pp.570~577 (2017)
- Na HS, "Intraoperative nefopam reduces acute postoperative pain after laparoscopic gastrectomy : a prospective, randomized study", J Gastrointest Surg, 22(5), pp.771~777 (2018)
- Yeo H, "The lack of analgesic efficacy of nefopam after video-assisted thoracoscopic surgery for lung cancer : a randomized, single-blinded, controlled trial", J Clin Med, 11(16), pp.4849~ (2022)
- Chalermkitpanit P, "Analgesic effect of intravenous nefopam for postoperative pain in minimally invasive spine surgery : a randomized prospective study", Asian Spine J, 16(5), pp.651~657 (2022)
- Liberati A, "The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions : explanation and elaboration", J Clin Epidemiol, 62(10), pp.e1~34 (2009)
- Moher D, "Preferred reporting items for systematic reviews and meta-analyses : the PRISMA statement", Open Med, 3(3), pp.e123~30 (2009)
- Higgins JPT, "Cochrane handbook for systematic reviews of interventions", pp.205~228 (2019), John Wiley & Sons
- Wan X, "Estimating the sample mean and standard deviation from the sample size, median, range and", or interquartile range, 2014, pp.14, 135~
- DerSimonian R, "Meta-analysis in clinical trials", Control Clin Trials, 7(3), pp.177~188 (1986)
- Higgins JP, "Quantifying heterogeneity in a meta-analysis", Stat Med, 21(11), pp.1539~1558 (2002)
- Piercey MF, "Spinal and Supraspinal sites for morphine and nefopam analgesia in the mouse", Eur J Pharmacol, 74(2-3), pp.135~140 (1981)
- Verleye M, "Nefopam blocks voltage-sensitive sodium channels and modulates glutamatergic transmission in rodents", Brain Res, 1013(2), pp.249~255 (2004)
- Novelli A, "Nefopam inhibits calcium influx, cGMP formation, and NMDA receptor-dependent neurotoxicity following activation of voltage sensitive calcium channels", Amino Acids, 28(2), pp.183~191 (2005)
- Lee JY, "The antiallodynic effect of nefopam on vincristine-induced neuropathy in mice", J Pain Res, 13, pp.323~329 (2020)
- Verleye M, "Contribution of transient receptor potential vanilloid subtype 1 to the analgesic and antihyperalgesic activity of nefopam in rodents", Pharmacology, 83(2), pp.116~121 (2009)
- Kim KH, "Rediscovery of nefopam for the treatment of neuropathic pain", Korean J Pain, 27(2), pp.103~111 (2014)
- Delage N, "Median effective dose(ED50)of nefopam and ketoprofen in postoperative patients : a study of interaction using sequential analysis and isobolographic analysis", Anesthesiology, 102(6), pp.1211~1216 (2005)
- Van Elstraete AC, "Median effective dose(ED50)of paracetamol and nefopam for postoperative pain : isobolographic analysis of their antinociceptive interaction", Minerva Anestesiol, 79(3), pp.232~239 (2013)
- Kim H, "Median effective dose of nefopam to treat postoperative pain in patients who have undergone laparoscopic cholecystectomy", J Int Med Res, 46(9), pp.3684~3691 (2018)